A potent cytotoxic photoactivated platinum complex
- 26 December 2007
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 104 (52), 20743-20748
- https://doi.org/10.1073/pnas.0707742105
Abstract
We show by x-ray crystallography that the complex trans, trans, trans-[Pt(N3)2(OH)2(NH3)(py)] (1) contains an octahedral PtIV center with almost linear azido ligands. Complex 1 is remarkably stable in the dark, even in the presence of cellular reducing agents such as glutathione, but readily undergoes photoinduced ligand substitution and photoreduction reactions. When 1 is photoactivated in cells, it is highly toxic: 13–80 x more cytotoxic than the PtII anticancer drug cisplatin, and ca. 15 x more cytotoxic toward cisplatin-resistant human ovarian cancer cells. Cisplatin targets DNA, and DNA platination levels induced in HaCaT skin cells by 1 were similar to those of cisplatin. However, cisplatin forms mainly intrastrand cis diguanine cross-links on DNA between neighboring nucleotides, whereas photoactivated complex 1 rapidly forms unusual trans azido/guanine, and then trans diguanine PtII adducts, which are probably mainly intrastrand cross-links between two guanines separated by a third base. DNA interstrand and DNA–protein cross-links were also detected. Importantly, DNA repair synthesis on plasmid DNA platinated by photoactivated 1 was markedly lower than for cisplatin or its isomer transplatin (an inactive complex). Single-cell electrophoresis experiments also demonstrated that the DNA damage is different from that induced by cisplatin or transplatin. Cell death is not solely dependent on activation of the caspase 3 pathway, and, in contrast to cisplatin, p53 protein did not accumulate in cells after photosensitization of 1. The trans diazido PtIV complex 1 therefore has remarkable properties and is a candidate for use in photoactivated cancer chemotherapy.Keywords
This publication has 32 references indexed in Scilit:
- Mechanism of the formation of DNA–protein cross-links by antitumor cisplatinNucleic Acids Research, 2007
- A Photoactivated trans‐Diammine Platinum Complex as Cytotoxic as CisplatinChemistry – A European Journal, 2006
- Detection of oxaliplatin-induced DNA crosslinks in vitro and in cancer patients using the alkaline comet assayDNA Repair, 2006
- Light-Activated Destruction of Cancer Cell Nuclei by Platinum Diazide ComplexesCell Chemical Biology, 2006
- cis-[Rh2(μ-O2CCH3)2(CH3CN)6]2+ as a Photoactivated Cisplatin AnalogJournal of the American Chemical Society, 2005
- Cisplatin: mode of cytotoxic action and molecular basis of resistanceOncogene, 2003
- Nucleotide Cross‐Linking Induced by Photoreactions of Platinum(IV)–Azide ComplexesAngewandte Chemie-International Edition, 2003
- Kinetic study of the reaction between an antitumor 15N labeled trans-platinum iminoether complex and GMP by [1H, 15N] HMQC NMRJ. Chem. Soc., Dalton Trans., 2002
- Toxicity determined in vitro by morphological alterations and neutral red absorptionToxicology Letters, 1985
- Heavy metal nucleotide interactions. 11. Stereochemical and electronic effects in the electrophilic attack of cis- and trans-diammineplatinum(II) on 5'-guanosine monophosphate and polyguanylate in aqueous solutionJournal of the American Chemical Society, 1978